Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
Ron Vachris ascended from a warehouse floor to Costco’s top job, a path that defies the usual degree-and-diploma rout...
Analysts warn that the global airline industry’s profits are set to fall sharply in 2026 as fuel bills rise and fligh...
From a quiet server builder to an AI infrastructure powerhouse, Super Micro Computer's decade-long rise shows how AI ...
Alphabet stands out as a durable cash engine blending a near-monopoly ad business with AI-driven cloud gains, offerin...
Ethereum neared the sub-$1.5K zone as selling pressure returned this week. The ethereum price prediction: close lens ...
Dell Technologies pivots from PC maker to AI infrastructure leader, as it visits higher backlog levels and raises rev...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
Industry lenders are speeding toward AI-driven processes in reverse mortgage operations, but legal experts warn that ...
Markets surge as investors debate mega-valuations tied to founder-led tech giants. This piece breaks down what everyd...
Discover how to read arbe (arbe) 2025 earnings from the Q4 transcript, uncover management priorities, and turn insigh...